1) Baoganxiaozhi Granula
保肝消脂冲剂
1.
Treatment of fatty liver of 52 cases by Baoganxiaozhi Granula;
保肝消脂冲剂治疗脂肪肝52例临床研究
2) Jiangzhi Baogan granules
降脂保肝冲剂
1.
The preparation and clinical application of Jiangzhi Baogan granules;
降脂保肝冲剂的制备及临床应用
3) Ganzhixiao mixture
肝脂消合剂
1.
Effect of Ganzhixiao Mixture on pathological histology of fatty liver mice model induced by high fat diet;
肝脂消合剂对高脂饮食致脂肪肝小鼠组织病理的影响
2.
Study on Quality Standard for Ganzhixiao Mixture;
肝脂消合剂质量标准的实验研究
3.
The experimental study indicates:Ganzhixiao Mixture can obviously reduce the high fat emulsion induce Hyperlipemia coulses blood serum TC,TG,LDL-C,ALT,AST content as well as elevates in the blood serum HDL-C,ALB content,prompts Ganzhixiao mixture has the function of blood fats adjustment and live protention.
实验研究表明:肝脂消合剂能明显降低高脂乳剂致高脂血症小鼠血清TC、TG、LDL-C、ALT、AST的含量以及升高血清中HDL-C、ALB的含量,提示肝脂消合剂具有调节血脂及保肝作用。
4) Ganzhixiao decoction
肝脂消煎剂
1.
Objective To explore the pharmacological mechanism of Ganzhixiao decoction(GZX)in treating fatty liver.
目的探讨肝脂消煎剂治疗脂肪肝药效学机制。
2.
Objective:To investigate the pharmacodynamics mechanism of Ganzhixiao decoction in treating fatty liver.
目的 :探讨肝脂消煎剂治疗脂肪肝药效学机制。
5) Ganzhixiao apozema
肝脂消煎剂
1.
Then rats were divided into four groups: normal control group, model control group, Ganzhixiao apozema treated group and Dongbaogantai treated group.
目的：观察肝脂消煎剂对脂肪肝大鼠血浆内毒素与肝组织NF-κB含量的影响，并探讨其作用机制。
2.
Objective: To observe the therapeutic effect of Ganzhixiao apozema and approach its mechanism of action by detecting the expression of liver s CD_(14) mRNA and LBP mRNA, and hepatic tissue s pathological section in FLD Rats.
目的： 通过对脂肪肝大鼠肝脏脂多糖受体CD_(14)mRNA、脂多糖结合蛋白LBPmRNA表达及肝脏病理检测，观察中药肝脂消煎剂对脂肪肝大鼠的治疗效应，并探讨其作用机制。
6) Baoganxiaozhi granule
保肝消脂颗粒
1.
Objective: The study validates clinical effect and security for treatment of alcoholic fatty liver with using Baoganxiaozhi granule by observing clinical cases.
目的:本课题通过对保肝消脂颗粒的临床病例观察,验证该药物治疗肝郁脾虚型酒精性脂肪肝的临床疗效以及安全性,并观察患者服用保肝消脂颗粒的情况,从而为肝郁脾虚型酒精性脂肪肝患者提供一种新的选择药物。
补充资料：消去
1.消失，消散。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条